Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

0.193
Delayed Data
As of Feb 12
 +0.006 / +3.21%
Today’s Change
0.15
Today|||52-Week Range
3.17
-45.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
AssetsCash45.0M33.3M32.0M45.5M
 
 
 
 
 
Short Term Investment Cash-22.5M-12.8M-1.3M13.5M
 
 
 
 
 
Cash & Short Term Investments97.7M76.6M98.3M88.3M
 
 
 
 
 
 
ReceivablesReceivables--0.00------
 
InventoriesInventories----------
 
Current AssetsOther Current Assets1.7M1.4M2.2M2.0M
 
 
 
 
 
Current Assets99.3M78.0M100.5M90.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross21.5M21.5M21.5M21.5M
 
 
 
 
 
Depreciation-20.5M-20.7M-20.8M-21.0M
 
 
 
 
 
Other Assets305.0K564.0K278.0K226.0K
 
 
 
 
 
Total Assets100.7M79.4M101.5M91.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.1M0.000.000.00
 
 
Short Term Debt9.3M9.3M9.3M7.0M
 
 
 
 
 
Accrued Expenses14.6M15.3M17.3M19.6M
 
 
 
 
 
Other Current Liabilities14.6M19.1M20.3M21.1M
 
 
 
 
 
Other Liabilities30.9M30.9M32.5M30.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt4.7M2.3M32.0K11.0K
 
 
 
 
 
Total Liabilities35.5M33.3M32.6M30.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity65.1M46.1M69.0M60.4M
 
 
 
 
 
Total Shareholder Equity65.1M46.1M69.0M60.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding109.1M109.1M134.1M137.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.